id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2020-0015-0013,DEA,DEA-2020-0015,Schedules of Controlled Substances: Placement of Zipeprol in Schedule I,Rule,,2022-11-21T05:00:00Z,2022,11,2022-11-21T05:00:00Z,,2022-11-21T13:29:53Z,2022-25206,0,0,09000064854f8125
DEA-2020-0015-0005,DEA,DEA-2020-0015,Zipeprol 8 Factor HHS 05202013,Supporting & Related Material,,2020-05-26T04:00:00Z,2020,5,,,2020-05-26T15:18:48Z,,0,0,09000064846ad53d
DEA-2020-0015-0004,DEA,DEA-2020-0015,Zipeprol 8 Factor May 2020,Supporting & Related Material,,2020-05-26T04:00:00Z,2020,5,,,2020-05-26T15:18:40Z,,0,0,09000064846ad53b
DEA-2020-0015-0003,DEA,DEA-2020-0015,Zipeprol HHS Letter 05202013,Supporting & Related Material,,2020-05-26T04:00:00Z,2020,5,,,2020-05-26T15:18:29Z,,0,0,09000064846ad90a
DEA-2020-0015-0001,DEA,DEA-2020-0015,Schedules of Controlled Substances: Placement of Zipeprol in Schedule I,Proposed Rule,,2020-05-14T04:00:00Z,2020,5,2020-05-14T04:00:00Z,2020-07-14T03:59:59Z,2020-07-14T01:01:18Z,2020-09592,0,0,09000064845f501a